Guangzhou Innogen Pharmaceutl Grp (2591.HK) Earnings Analysis
Guangzhou Innogen Pharmaceutl Grp (2591.HK) next reports earnings on 2026-08-30. Trailing P/E -9.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2591.HK next report earnings?
| Next earnings date | 2026-08-30 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2591.HK earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
2591.HK valuation and analyst view
| Trailing P/E | -9.01 |
|---|---|
| Trailing EPS | -0.7581 HKD |
| Price / book | 2.91 |
| Dividend yield | 0.00% |
| Market cap | 3.81B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Guangzhou Innogen Pharmaceutl Grp (2591.HK)'s next earnings date?
Guangzhou Innogen Pharmaceutl Grp is next scheduled to report on 2026-08-30.
What is 2591.HK's current P/E ratio and EPS?
2591.HK trades at a trailing P/E of -9.01 on trailing EPS of -0.7580993455657216 HKD.
What do analysts rate 2591.HK?
2591.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.